Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Kodiak Sciences Inc.KOD · Entity 4388 | See Remarks | June 24, 2023 | June 27, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Kodiak Sciences Inc.
Report date June 24, 2023 · Filed June 27, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.24 · Expires 2033-06-23 | Direct | 207,500 |
Reported balance
After 2023-06-24 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-06-24 · Grant · Acquired 207,500 · Balance 207,500 F1: One-forty-eighth (1/48th) of the shares vest one month after July 1, 2023 (the "Vesting Commencement Date"); the balance of the shares vest in a series of forty-seven (47) successive equal monthly installments measured from the first month anniversary of the Vesting Commencement Date, subject to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: One-forty-eighth (1/48th) of the shares vest one month after July 1, 2023 (the "Vesting Commencement Date"); the balance of the shares vest in a series of forty-seven (47) successive equal monthly installments measured from the first month anniversary of the Vesting Commencement Date, subject to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 20, 2020 Filed Mar 24, 2020 20:45 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 344 | $47.44 | $16,317.64 |
DisclosureSEC source: 0001209191-20-020946 · doc4.xml · nonDerivative · entry 7 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,670 F1 · kind: The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan. F7 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $47.145 to $48.105, inclusive. Read SEC document |
| March 20, 2020 Filed Mar 24, 2020 20:45 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 1,917 | $46.18 | $88,523.23 |
DisclosureSEC source: 0001209191-20-020946 · doc4.xml · nonDerivative · entry 6 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,014 F1 · kind: The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan. F6 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $46.00 to $47.00, inclusive. Read SEC document |
| March 20, 2020 Filed Mar 24, 2020 20:45 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 750 | $45.54 | $34,158.00 |
DisclosureSEC source: 0001209191-20-020946 · doc4.xml · nonDerivative · entry 5 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,931 F1 · kind: The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan. F5 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $45.07 to $45.99, inclusive. Read SEC document |
| March 20, 2020 Filed Mar 24, 2020 20:45 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 2,120 | $44.40 | $94,134.36 |
DisclosureSEC source: 0001209191-20-020946 · doc4.xml · nonDerivative · entry 4 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,681 F1 · kind: The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $43.985 to $44.96, inclusive. Read SEC document |
| March 20, 2020 Filed Mar 24, 2020 20:45 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 1,458 | $43.59 | $63,549.85 |
DisclosureSEC source: 0001209191-20-020946 · doc4.xml · nonDerivative · entry 3 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,801 F1 · kind: The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $42.955 to $43.93, inclusive. Read SEC document |
| March 20, 2020 Filed Mar 24, 2020 20:45 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 233 | $42.32 | $9,860.09 |
DisclosureSEC source: 0001209191-20-020946 · doc4.xml · nonDerivative · entry 2 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,259 F1 · kind: The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $41.775 to $42.71, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes. Read SEC document |
| March 20, 2020 Filed Mar 24, 2020 20:45 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionCommon Stock | 6,950 | $10.29 | $71,515.50 |
DisclosureSEC source: 0001209191-20-020946 · doc4.xml · nonDerivative · entry 1 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,492 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 30, 2019 Filed Jan 2, 2020 22:31 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | GrantStock Option (Right to Buy) · Derivative | 93,000 | $0.00 Strike: $73.51 | $0.00 |
DisclosureSEC source: 0001209191-20-000403 · doc4.xml · derivative · entry 1 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,000 Underlying: Common Stock · 93,000 shares Expires 2029-12-29 F1 · derivative.exercise_date: 1/48th of the shares subject to the option will vest on January 30, 2020, and 1/48th of the shares subject to the option vest on the same day of each month thereafter, subject to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) as of each such date. Read SEC document |
| December 23, 2019 Filed Dec 27, 2019 22:53 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,075 | $0.00 Strike: $10.29 | $0.00 |
DisclosureSEC source: 0001209191-19-062040 · doc4.xml · derivative · entry 2 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 423,925 Underlying: Common Stock · 1,075 shares Expires 2028-08-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vested on September 1, 2019 and 1/48th of the shares subject to the option vest on the same day of each month thereafter. Read SEC document |
| December 23, 2019 Filed Dec 27, 2019 22:53 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionCommon Stock | 1,075 | $10.29 | $11,061.75 |
DisclosureSEC source: 0001209191-19-062040 · doc4.xml · nonDerivative · entry 1 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,542 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 18, 2019 Filed Dec 20, 2019 23:23 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionRestricted Stock Units · Derivative | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-061638 · doc4.xml · derivative · entry 3 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's common stock. F3 · derivative.exercise_date: 50% of the RSUs vested 12 months after October 9, 2018 (the "Grant Date"), 25% of the RSUs vest 18 months after the Grant Date and 25% of the RSUs vest 24 months after the Grant Date. F3 · derivative.expiration_date: 50% of the RSUs vested 12 months after October 9, 2018 (the "Grant Date"), 25% of the RSUs vest 18 months after the Grant Date and 25% of the RSUs vest 24 months after the Grant Date. Read SEC document |
| December 18, 2019 Filed Dec 20, 2019 23:23 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Tax withholdingCommon Stock | 8,533 | $15.51 | $132,346.83 |
DisclosureSEC source: 0001209191-19-061638 · doc4.xml · nonDerivative · entry 2 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,467 F2 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain RSUs previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| December 18, 2019 Filed Dec 20, 2019 23:23 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionCommon Stock | 30,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-061638 · doc4.xml · nonDerivative · entry 1 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's common stock. Read SEC document |
| July 16, 2019 Filed Jul 18, 2019 21:47 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | GrantStock Option (Right to Buy) · Derivative | 93,000 | $0.00 Strike: $14.23 | $0.00 |
DisclosureSEC source: 0000899243-19-019932 · doc4.xml · derivative · entry 1 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,000 Underlying: Common Stock · 93,000 shares Expires 2029-07-15 F1 · derivative.exercise_date: One forty-eighth of the shares subject to the option will vest on August 16, 2019, and 1/48th of the shares subject to the option vest on the same day of each month thereafter, subject to the Reporting Person's continuous service as a service provider on each such date. Read SEC document |
| October 09, 2018 Filed Oct 9, 2018 21:54 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | GrantRestricted Stock Units · Derivative | 60,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-026450 · doc4.xml · derivative · entry 1 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's common stock. F2 · derivative.exercise_date: Fifty percent of the RSUs vest 12 months after October 9, 2018 (the "Grant Date"), 25% of the RSUs vest 18 months after the Grant Date and 25% of the RSUs vest 24 months after the Grant Date. F2 · derivative.expiration_date: Fifty percent of the RSUs vest 12 months after October 9, 2018 (the "Grant Date"), 25% of the RSUs vest 18 months after the Grant Date and 25% of the RSUs vest 24 months after the Grant Date. Read SEC document |
| October 03, 2018 Filed Oct 5, 2018 20:19 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | GrantStock Option (Right to Buy) · Derivative | 56,682 | $0.00 Strike: $10.00 | $0.00 |
DisclosureSEC source: 0000899243-18-026300 · doc4.xml · derivative · entry 1 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,682 Underlying: Common Stock · 56,682 shares Expires 2028-10-02 F1 · derivative.exercise_date: One-sixtieth of the shares subject to the option will vest on November 3, 2018, and 1/60th of the shares subject to the option vest on the same day of each month thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.